Latest Non-Hodgkin lymphoma Stories
Scientists say patients with certain forms of aggressive Non-Hodgkin’s Lymphoma are more likely to survive if they respond well to their first treatment. Raleigh,
NIH researchers say risks from occupational exposures such as PCBs cannot be ruled out. Raleigh, NC (PRWEB) March 15, 2014 Researchers with the National
Researchers say a combination of bendamustine and rituximab may be just as effective and less toxic than standard chemotherapy for indolent lymphomas. Raleigh,
Targeted drug aims to address high recurrence and lower survival in people with B-cell cancers. Raleigh, NC (PRWEB) March 10, 2014 The Non-Hodgkin’s
Two new studies in major medical journals may help doctors understand how Non-Hodgkin’s Lymphoma starts, and predict treatment outcomes. Raleigh, NC (PRWEB)
A new article in a top medical journal says appropriate use of a safer chemotherapy drug could open up more treatment options for Non-Hodgkin’s Lymphoma patients. Raleigh,
Researchers say reduced white blood cell count with chemotherapy could be corrected with appropriate medication. Raleigh, NC (PRWEB) March 03, 2014 Researchers
A Canadian lymphoma expert says the ability to understand the influence of genes in disease could be a vital step forward in the treatment of Non-Hodgkin’s Lymphoma. Raleigh,
Korean researchers say a combination of techniques improves diagnostic accuracy for several types of Non-Hodgkin’s Lymphoma. Raleigh, NC (PRWEB) March 01,
Mayo Clinic researchers say the identification of a mutated gene frequently found in Non-Hodgkin’s Lymphoma may open the door to new treatments. Raleigh, NC
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.